Brickell Biotech (NASDAQ: BBI)
|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Brickell Biotech (NASDAQ: BBI) through any online brokerage.
The latest price target for Brickell Biotech (NASDAQ: BBI) was reported by Lake Street on Friday, May 13, 2022. The analyst firm set a price target for 0.00 expecting BBI to fall to within 12 months (a possible -100.00% downside). 3 analyst firms have reported ratings in the last year.
The stock price for Brickell Biotech (NASDAQ: BBI) is $3.63 last updated August 9, 2022, 8:00 PM UTC.
There are no upcoming dividends for Brickell Biotech.
Brickell Biotech’s Q3 earnings are confirmed for Tuesday, November 8, 2022.
There is no upcoming split for Brickell Biotech.
Brickell Biotech is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.